SCHEMBL8102488

SCHEMBL8102488

NC(=O)C1=Cc2ccccc2C1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDC25B P30305 2/20 0.43
▸ CDC25A P30304 1/20 0.43
▸ KEAP1 Q14145 1/20 0.42
▸ NFE2L2 Q16236 1/20 0.42
▸ MEN1 O00255 5/20 0.41
▸ KMT2A Q03164 5/20 0.41
▸ MAPT P10636 4/20 0.41
▸ POLB P06746 3/20 0.41
▸ RECQL P46063 3/20 0.41
▸ KDM4E B2RXH2 3/20 0.41
▸ LMNA P02545 3/20 0.41
▸ HSD17B10 Q99714 2/20 0.41
▸ BCHE P06276 2/20 0.41
▸ PTPRC P08575 2/20 0.41
▸ THRB P10828 2/20 0.41
▸ CES1 P23141 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ HPGD P15428 2/20 0.41
▸ PTPN1 P18031 2/20 0.41
▸ PTPN22 Q9Y2R2 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7354968 0.82 MAOA (0.50) CDC25BCDC25AMEN1KMT2AMAPT
SCHEMBL30645249 0.80 CDC25B (0.47) CDC25BCDC25AMEN1KMT2AMAPT
SCHEMBL28865505 0.80 CDC25A (0.48) CDC25BCDC25AKEAP1NFE2L2MEN1
SCHEMBL27358025 0.77 FGFR1 (0.46) CDC25BCDC25AMAPTPOLBKDM4E
SCHEMBL28211937 0.76 MAOA (0.49) CDC25BCDC25AMEN1KMT2AMAPT
SCHEMBL2124709 0.76 MEN1 (0.43) KEAP1NFE2L2MEN1KMT2AMAPT
SCHEMBL11409080 0.74 CDC25B (0.50) CDC25BCDC25AMEN1KMT2AMAPT
SCHEMBL31127006 0.74 CES1 (0.41) CDC25BCDC25AMEN1KMT2AMAPT
SCHEMBL10496201 0.73 MEN1 (0.49) KEAP1NFE2L2MEN1KMT2AMAPT
SCHEMBL27264312 0.73 CES1 (0.46) CDC25BCDC25AMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6013674-A INDENONE AMIDE DERIVATIVES, USEFUL FOR FOR THE INHIBITION OF LEUKOCYTE ADHERENCE TO ENDOTHELIAL CELLS; USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASES, AS ARTHRITIS, ASTHAMA, PSORIASIS, RESPIRATORY DISTRESS SYNDROME, STROKE AND ULCER ELI LILLY AND COMPANY (US) 2000-01-11 — — US disclosed
EP-0882706-A1 Cell adhesion inhibitors ELI LILLY AND COMPANY (US) 1998-12-09 — — EP disclosed
Send feedback